Business Context and Reporting Period
This Form 8-K is filed by American BriVision (Holding) Corporation (also referenced as ABVC Biopharma, Inc. in metadata) for the reporting period ending November 27, 2017, covering events occurring on November 20, 2017. The filing addresses a change in the company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the administrative change of auditors.
Material Changes
- Dismissal of Former Auditor: On November 17, 2017, the Company notified Centurion ZD CPA Limited of its dismissal, effective November 20, 2017. Centurion served as auditor from the company's inception (July 21, 2015) through November 20, 2017.
- Appointment of New Auditor: On November 22, 2017, the Board appointed KCCW Accountancy Corp as the new independent registered public accounting firm for the fiscal year ended September 30, 2017.
- Audit History: The former auditor's reports for the fiscal years ended September 30, 2015, and September 30, 2016, did not contain adverse opinions or disclaimers. However, the 2016 report included an explanatory paragraph raising substantial doubt about the Company's ability to continue as a going concern.
- Disagreements: There were no disagreements with the former auditor regarding accounting principles, practices, or audit scope during their tenure.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the historical "going concern" qualification noted in the 2016 audit report. The Company plans to disclose the former auditor's consent letter via an amendment to this report upon receipt.
Investor Verification Checklist
- Verify the receipt of the Consent Letter from Centurion ZD CPA Limited to confirm no undisclosed disagreements exist.
- Review the upcoming financial statements audited by KCCW Accountancy Corp to assess the current status of the "going concern" uncertainty.
- Confirm the Company's operational status and liquidity position given the historical going concern warning.